By analyzing the correlation between Trop-2 expression and baseline tumor characteristics, they found that higher Trop-2 expression was associated with apocrine histology, higher androgen receptor (AR) expression, ductal carcinoma in situ (DCIS), lymphovascular invasion (LVI), and lymph node involvement. The gene discussed is TACSTD2; the disease is neoplasm.